Overview

Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to FloventĀ® HFA 110 mcg

Status:
Completed
Trial end date:
2021-07-09
Target enrollment:
Participant gender:
Summary
A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study to Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to FloventĀ® HFA 110 mcg, in Adult Subjects with Asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Actavis Inc.
Collaborator:
Teva Pharmaceuticals USA
Treatments:
Fluticasone
Xhance